RECK and colorectal cancer: Conversely, the membrane anchored MMP inhibitor RECK (reversion inducing cysteine-rich protein with kazal motifs) has been shown by Takeuchi et al (2004) to correlate inversely with recurrence and microvessel formation in colorectal cancer.